<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:40:07Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9314590" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9314590</identifier>
        <datestamp>2022-07-30</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="clr13914" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Oral Implants Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Oral Implants Res</journal-id>
              <journal-id journal-id-type="doi">10.1111/(ISSN)1600-0501</journal-id>
              <journal-id journal-id-type="publisher-id">CLR</journal-id>
              <journal-title-group>
                <journal-title>Clinical Oral Implants Research</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0905-7161</issn>
              <issn pub-type="epub">1600-0501</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9314590</article-id>
              <article-id pub-id-type="pmcid">PMC9314590</article-id>
              <article-id pub-id-type="pmc-uid">9314590</article-id>
              <article-id pub-id-type="pmid">35238084</article-id>
              <article-id pub-id-type="pmid">35238084</article-id>
              <article-id pub-id-type="doi">10.1111/clr.13914</article-id>
              <article-id pub-id-type="publisher-id">CLR13914</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Non‐surgical peri‐implantitis treatment with or without systemic antibiotics: a randomized controlled clinical trial</article-title>
                <alt-title alt-title-type="left-running-head">POLYMERI et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="clr13914-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Polymeri</surname>
                    <given-names>Angeliki</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5583-0365</contrib-id>
                  <xref rid="clr13914-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>a.polymeri@acta.nl</email>
                  </address>
                </contrib>
                <contrib id="clr13914-cr-0002" contrib-type="author">
                  <name>
                    <surname>van der Horst</surname>
                    <given-names>Joyce</given-names>
                  </name>
                  <xref rid="clr13914-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="clr13914-cr-0003" contrib-type="author">
                  <name>
                    <surname>Anssari Moin</surname>
                    <given-names>David</given-names>
                  </name>
                  <xref rid="clr13914-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="clr13914-cr-0004" contrib-type="author">
                  <name>
                    <surname>Wismeijer</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6736-1941</contrib-id>
                  <xref rid="clr13914-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="clr13914-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="clr13914-cr-0005" contrib-type="author">
                  <name>
                    <surname>Loos</surname>
                    <given-names>Bruno G.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8794-552X</contrib-id>
                  <xref rid="clr13914-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="clr13914-cr-0006" contrib-type="author">
                  <name>
                    <surname>Laine</surname>
                    <given-names>Marja L.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6052-041X</contrib-id>
                  <xref rid="clr13914-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="clr13914-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Periodontology</named-content>
                <named-content content-type="organisation-division">Academic Centre for Dentistry Amsterdam (ACTA)</named-content>
                <institution>University of Amsterdam and VU Amsterdam</institution>
                <city>Amsterdam</city>
                <country country="NL">the Netherlands</country>
              </aff>
              <aff id="clr13914-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Oral Implantology and Prosthetic Dentistry</named-content>
                <named-content content-type="organisation-division">Academic Centre for Dentistry Amsterdam (ACTA)</named-content>
                <institution>University of Amsterdam and VU Amsterdam</institution>
                <city>Amsterdam</city>
                <country country="NL">the Netherlands</country>
              </aff>
              <aff id="clr13914-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <institution>TPE</institution>
                <institution>Private Practice</institution>
                <city>Ellecom</city>
                <country country="NL">the Netherlands</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Angeliki Polymeri, Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), Gustav Mahlerlaan 3004, 1081 LA Amsterdam, The Netherlands.<break/>
Email: <email>a.polymeri@acta.nl</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>15</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <volume>33</volume>
              <issue seq="100">5</issue>
              <issue-id pub-id-type="doi">10.1111/clr.v33.5</issue-id>
              <fpage>548</fpage>
              <lpage>557</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>23</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="received">
                  <day>28</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--Copyright &#x000a9; 2022 John Wiley & Sons A/S-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Clinical Oral Implants Research</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:CLR-33-548.pdf"/>
              <abstract id="clr13914-abs-0001">
                <title>Abstract</title>
                <sec id="clr13914-sec-0001">
                  <title>Objectives</title>
                  <p>To assess the adjunctive effect of systemic amoxicillin (AMX) and metronidazole (MTZ) in patients receiving non‐surgical treatment (NST) for peri‐implantitis (PI).</p>
                </sec>
                <sec id="clr13914-sec-0002">
                  <title>Materials and methods</title>
                  <p>Thirty‐seven patients were randomized into an experimental group treated with NST plus AMX + MTZ (N = 18) and a control group treated with NST alone (N = 19). Clinical parameters were evaluated at 12 weeks post‐treatment. The primary outcome was the change in peri‐implant pocket depth (PIPD) from baseline to 12 weeks, while secondary outcomes included bleeding on probing (BoP), suppuration on probing (SoP), and plaque. Data analysis was performed at patient level (one target site per patient).</p>
                </sec>
                <sec id="clr13914-sec-0003">
                  <title>Results</title>
                  <p>All 37 patients completed the study. Both groups showed a significant PIPD reduction after NST. The antibiotics group showed a higher mean reduction in PIPD at 12 weeks, compared with the control group (2.28 ± 1.49 mm vs. 1.47 ± 1.95 mm), however, this difference did not reach statistical significance. There was no significant effect of various potential confounders on PIPD reduction. Neither treatment resulted in significant improvements in BoP at follow‐up; 30 of 37 (81%) target sites still had BoP after treatment. Only two implants, one in each group, exhibited a successful outcome defined as PIPD &lt; 5 mm, and absence of BoP and SoP.</p>
                </sec>
                <sec id="clr13914-sec-0004">
                  <title>Conclusions</title>
                  <p>Non‐surgical treatment was able to reduce PIPD at implants with PI. The adjunctive use of systemic AMX and MTZ did not show statistically significant better results compared to NST alone. NST with or without antibiotics was ineffective to completely resolve inflammation around dental implants.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd id="clr13914-kwd-0001">bacteria</kwd>
                <kwd id="clr13914-kwd-0002">debridement</kwd>
                <kwd id="clr13914-kwd-0003">non‐surgical treatment</kwd>
                <kwd id="clr13914-kwd-0004">peri‐implantitis</kwd>
                <kwd id="clr13914-kwd-0005">systemic antibiotics</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>Department of Periodontology and Department of Oral Implantology and Prosthetic Dentistry, Academic Centre for Dentistry Amsterdam (ACTA).</funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="3"/>
                <page-count count="10"/>
                <word-count count="7225"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>May 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:26.07.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="clr13914-cit-1001"><string-name><surname>Polymeri</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>van der Horst</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Anssari Moin</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wismeijer</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Loos</surname>, <given-names>B. G.</given-names></string-name>, &amp; <string-name><surname>Laine</surname>, <given-names>M. L.</given-names></string-name> (<year>2022</year>). <article-title>Non‐surgical peri‐implantitis treatment with or without systemic antibiotics: a randomized controlled clinical trial</article-title>. <source>Clinical Oral Implants Research</source>, <volume>33</volume>, <fpage>548</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1111/clr.13914</pub-id>
<pub-id pub-id-type="pmid">35238084</pub-id></mixed-citation>
              </p>
              <fn-group id="clr13914-ntgp-0001">
                <fn fn-type="funding" id="clr13914-note-0001">
                  <p>
                    <bold>Funding information</bold>
                  </p>
                  <p>This study was supported by the Department of Periodontology and the Department of Oral Implantology and Prosthetic Dentistry, Academic Centre for Dentistry Amsterdam (ACTA).</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="clr13914-body-0001">
            <sec id="clr13914-sec-0005">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>The importance of biofilms in the etiology of peri‐implantitis (PI), as an initial trigger for inflammatory reactions, has been well established (Lindhe et al., <xref rid="clr13914-bib-0018" ref-type="bibr">1992</xref>). Dysbiotic biofilms may cause tissue inflammation, which alters the ecology and favors further growth of dysbiotic microbial communities, leading to a vicious cycle, similar to periodontitis (Hajishengallis et al., <xref rid="clr13914-bib-0009" ref-type="bibr">2020</xref>; Loos &amp; Van Dyke, <xref rid="clr13914-bib-0020" ref-type="bibr">2020</xref>).</p>
              <p>Although the microbial composition associated with PI is similar to periodontitis, the peri‐implant microbiome is more complex including non‐cultivable gram‐negative species (Lafaurie et al., <xref rid="clr13914-bib-0014" ref-type="bibr">2017</xref>). Well‐recognized periodontal pathogens such as <italic toggle="yes">Fusobacterium nucleatum</italic>, <italic toggle="yes">Prevotella intermedia</italic>, and <italic toggle="yes">Treponema denticola</italic> are present in higher proportions in deep peri‐implant pockets (Polymeri et al., <xref rid="clr13914-bib-0029" ref-type="bibr">2021</xref>). Consequently, the current protocols for the treatment of PI are based on the evidence available from periodontal treatment and focus on resolution of inflammation and elimination of biofilm from the implant surfaces (Renvert &amp; Polyzois, <xref rid="clr13914-bib-0033" ref-type="bibr">2018</xref>). Although most periodontitis cases respond favorably to treatment and maintain long‐term periodontal stability (Lindhe &amp; Nyman, <xref rid="clr13914-bib-0019" ref-type="bibr">1984</xref>), this does not hold true for PI; most probably due to structural differences in supporting tissues between implants and teeth, differences in the histopathologic features of the two lesions, and the surface characteristics of implants (de Avila et al., <xref rid="clr13914-bib-0005" ref-type="bibr">2020</xref>; Berglundh et al., <xref rid="clr13914-bib-0002" ref-type="bibr">2011</xref>). Therefore, existing therapeutic strategies are unpredictable in arresting peri‐implant tissue inflammation and current evidence does not support a gold standard treatment protocol (Garaicoa‐Pazmino et al., <xref rid="clr13914-bib-0008" ref-type="bibr">2019</xref>).</p>
              <p>As that may be, the non‐surgical treatment (NST) is the first step in PI treatment and may lead to some reduction in the extent of inflammation and in some cases to peri‐implant pocket depth (PIPD) reduction of up to 1 mm (Renvert et al., <xref rid="clr13914-bib-0032" ref-type="bibr">2019</xref>). The adjunctive use of antibiotics, especially metronidazole (MTZ) or the combination of amoxicillin (AMX) and MTZ, in the non‐surgical treatment of periodontitis has been widely investigated and has shown to improve the clinical and microbiological parameters (Berglundh et al., <xref rid="clr13914-bib-0001" ref-type="bibr">1998</xref>; Teughels &amp; Feres, <xref rid="clr13914-bib-0039" ref-type="bibr">2020</xref>). Antimicrobials have also been proposed for PI treatment and are widely used empirically by clinicians from all over the globe, although the scientific evidence of their benefits is still limited (Heitz‐Mayfield &amp; Lang, <xref rid="clr13914-bib-0011" ref-type="bibr">2004</xref>; Polymeri et al., <xref rid="clr13914-bib-0028" ref-type="bibr">2021</xref>). Several studies have demonstrated that the adjunctive administration of systemic antibiotics has led to favorable results in terms of PIPD, tissue inflammation, and even radiographic defect reduction (Blanco et al., <xref rid="clr13914-bib-0003" ref-type="bibr">2022</xref>; Liñares et al., <xref rid="clr13914-bib-0017" ref-type="bibr">2019</xref>; Mombelli &amp; Lang, <xref rid="clr13914-bib-0023" ref-type="bibr">1992</xref>; Nart et al., <xref rid="clr13914-bib-0025" ref-type="bibr">2020</xref>; Stein et al., <xref rid="clr13914-bib-0038" ref-type="bibr">2018</xref>). On the other hand, two RCTs have shown no additional benefit to NST when systemic antibiotics were used adjunctively (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>; Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>). Hence, the scientific evidence for the use of systemic antibiotics in combination with NST for PI is still inconclusive.</p>
              <p>Some of the aforementioned studies used a single antimicrobial of the nitroimidazole group, most frequently metronidazole (Blanco et al., <xref rid="clr13914-bib-0003" ref-type="bibr">2022</xref>; Liñares et al., <xref rid="clr13914-bib-0017" ref-type="bibr">2019</xref>; Nart et al., <xref rid="clr13914-bib-0025" ref-type="bibr">2020</xref>) and ornidazole (Mombelli &amp; Lang, <xref rid="clr13914-bib-0023" ref-type="bibr">1992</xref>). On the other hand, other studies preferred the combination of amoxicillin and metronidazole (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>; Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>; Stein et al., <xref rid="clr13914-bib-0038" ref-type="bibr">2018</xref>). An in vitro study showed that the combination of metronidazole and amoxicillin was effective in lower concentration than mono‐therapy, suggesting a synergistic mode of action for these agents (Walter et al., <xref rid="clr13914-bib-0041" ref-type="bibr">2011</xref>). Therefore, we chose to use the combination of amoxicillin and metronidazole at low concentrations.</p>
              <p>The purpose of the present randomized controlled clinical trial of PI treatment was to evaluate the clinical results of the combined use of systemic AMX and MTZ in conjunction with NST, in comparison to NST alone. The null hypothesis was that there are no differences between the two treatment strategies.</p>
            </sec>
            <sec sec-type="materials-and-methods" id="clr13914-sec-0006">
              <label>2</label>
              <title>MATERIALS AND METHODS</title>
              <sec id="clr13914-sec-0007">
                <label>2.1</label>
                <title>Study design and ethical approval</title>
                <p>The study was carried out as a randomized, controlled, single‐blinded, clinical trial. The study protocol was approved by the ethical committee of the VU Medical Centre, Amsterdam (NL 39371.018.12), and was registered at the ISRCTN (<ext-link xlink:href="https://www.isrctn.com/ISRCTN10896644" ext-link-type="uri">https://www.isrctn.com/ISRCTN10896644</ext-link>). The study was conducted in accordance with the principles outlined in the revision of the Declaration of Helsinki (2008).</p>
              </sec>
              <sec id="clr13914-sec-0008">
                <label>2.2</label>
                <title>Study population</title>
                <p>The present study is in compliance with the CONSORT guidelines. The study participants were referred to the Department of Oral Implantology and Prosthetic Dentistry or the Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), for treatment of PI.</p>
                <p>Systemically healthy, adult patients (≥18 years old) with at least one dental implant were included, if the implant had been in function for more than 1 year, presented with PIPD ≥5 mm, bleeding and/or suppuration on probing (BoP and/or SoP), as well as marginal bone loss ≥3 mm detected radiographically. Exclusion criteria included the use of systemic antibiotics within the past 3 months, any chronic medical disease or condition, known allergy to penicillin or metronidazole, use of anti‐inflammatory prescription medications within the past 4 weeks, pregnancy or lactation, and presence of implant mobility. Each participant was informed about the aims, the potential risks and benefits of the study, and provided written informed consent. The long‐cone parallel technique was performed for the digital radiographic evaluation. The implant with the deepest PIPD was selected for the study (target implant). For each target implant, the PIPD was evaluated at six sites and the deepest of them was defined as “target site” and was selected for analysis.</p>
                <p>The study was conducted between 2012 and 2018. The limited availability of referral cases which fulfilled the inclusion criteria, and the fact that the individuals who were responsible for recruiting the patients, making clinical evaluations, and providing the treatment (D.A.M. and J.V.D.H.) were working at ACTA part‐time, delayed the completion of the study. Using a block randomization design, patients who met the inclusion criteria were assigned into one of the following treatment protocols: non‐surgical treatment (NST) with systemic antibiotics (AMX and MTZ) and chlorhexidine rinses (experimental group) or NST with chlorhexidine rinses (control group) (Figure <xref rid="clr13914-fig-0001" ref-type="fig">1</xref>).</p>
                <fig position="float" fig-type="FIGURE" id="clr13914-fig-0001">
                  <label>FIGURE 1</label>
                  <caption>
                    <p>Consort diagram of patient distribution</p>
                  </caption>
                  <graphic xlink:href="CLR-33-548-g003" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
              <sec id="clr13914-sec-0009">
                <label>2.3</label>
                <title>Non‐surgical treatment and follow‐up</title>
                <p>After anamneses, clinical and radiographic assessments, and prophylaxis/oral hygiene instruction, the participants received one session of mechanical debridement. After local anesthesia (Ultracain‐DS forte<sup>®</sup>, Sanofi, Frankfurt, Germany), the implant surfaces were treated with ultrasonic devices (EMS, Electro Medical Systems, Nyon, Switzerland) with the Polyether Ether Ketone (PEEK) fiber tip (PI instrument<sup>®</sup>, EMS, Nyon, Switzerland), and carbon fiber reinforced plastic hand instruments (Universal Implant Deplaquer<sup>®</sup>; Kerr Dental, Bioggio, Switzerland). The implant supported restorations were not removed during treatment. The treatment was performed by one experienced clinician (J.V.D.H.). On the day of treatment, patients started with systemic AMX 375 mg and MTZ 250 mg, 1 tablet each, every 8 h for 7 days. All patients were instructed to start rinsing with chlorhexidine 0.12%, two times a day for 4 weeks. In those patients presented with periodontitis, this was treated first and more sessions were planned if necessary to complete the treatment of the whole dentition. At 4 weeks, an oral hygiene check was performed which included supragingival debridement, polishing with a rubber cup and a low‐abrasive paste, and oral hygiene instructions as needed.</p>
                <p>Twelve weeks after treatment, a clinical examination was performed in order to evaluate the outcome of treatment. A successful outcome was defined based on the following clinical criteria: implant survival with absence of PIPD ≥5 mm, and absence of BoP and/or SoP, modified from Heitz‐Mayfield et al. (<xref rid="clr13914-bib-0012" ref-type="bibr">2018</xref>). The modification is based on the exclusion of the radiographic evaluation at 12 weeks, as it has been established that the radiographic evaluation does not permit accurate detection of minor resorptive changes in the crestal bone (Ramadan &amp; Mitchell, <xref rid="clr13914-bib-0030" ref-type="bibr">1962</xref>). Treatment success was assessed at target site level and at patient level. In case of an unsuccessful outcome, the patient was advised to seek further surgical treatment either at ACTA or at the referring dentist or referring oral surgeon, but this was outside the scope of the current study. In case of treatment success, the patient entered into a 3‐month recall program, consisting of soft tissue examination, oral hygiene reinforcement as needed, supragingival instrumentation, and annual clinical evaluation.</p>
              </sec>
              <sec id="clr13914-sec-0010">
                <label>2.4</label>
                <title>Demographic data</title>
                <p>At the beginning of the study, the following demographic data were recorded: age, sex, body mass index (BMI; expressed as kg/m²), smoking status (smoker, non‐smoker), history of periodontitis (yes/no), periodontal stability (yes/no), full mouth plaque score (presence/absence, %), implant position (maxilla/mandible and anterior/posterior), type of prosthesis connection (screw vs. cement retained), dental status (partially edentulous/fully edentulous), number of dental implants (≥4 vs. &lt;4), and implant brand.</p>
                <p>A periodontitis case was determined on the basis of clinical attachment loss (CAL). When interdental CAL was detected at ≥2 non‐adjacent teeth or buccal or oral CAL ≥3 mm with probing depths &gt;3 mm detectable in ≥2 teeth, and the observed CAL could not be associated with non‐periodontitis related causes, the patient was considered a periodontitis case (Papapanou et al., <xref rid="clr13914-bib-0026" ref-type="bibr">2018</xref>). In cases of fully edentulous patients, where previous periodontal charts or radiographs were not available, history of periodontitis was self‐reported by the patient. Periodontal stability was defined as &lt;10% bleeding sites with probing depths ≤3 mm (Chapple et al., <xref rid="clr13914-bib-0004" ref-type="bibr">2018</xref>).</p>
              </sec>
              <sec id="clr13914-sec-0011">
                <label>2.5</label>
                <title>Clinical examination</title>
                <p>Baseline clinical measurements of the target implant included: (1) PIPD measured to the closest mm from the mucosal margin to the base of the pocket, (2) BoP (presence or absence), (3) SoP (presence or absence), and (4) plaque (presence or absence). All clinical measurements were performed at six sites. The above clinical measurements were repeated at 12 weeks. All clinical measurements were performed using a periodontal probe (PCP‐UNC 15; Hu‐Friedy, Chicago, IL, USA) by one calibrated examiner (D.A.M.) who was blinded to the study group allocation.</p>
              </sec>
              <sec id="clr13914-sec-0012">
                <label>2.6</label>
                <title>Statistical analysis</title>
                <p>At the time of the study design, no data from RCTs were available for the non‐surgical treatment of PI with the use of systemic antibiotics, therefore the power calculation to determine the sample size was based on a previous study of periodontal patients receiving non‐surgical treatment alone or combined with AMX and MTZ (Silva et al., <xref rid="clr13914-bib-0037" ref-type="bibr">2011</xref>). The sample size was calculated at <ext-link xlink:href="https://clincalc.com/stats/samplesize.aspx" ext-link-type="uri">https://clincalc.com/stats/samplesize.aspx</ext-link> considering a mean difference in PIPD after treatment of 1 mm between the experimental and control group with standard deviation of 1 mm (Silva et al., <xref rid="clr13914-bib-0037" ref-type="bibr">2011</xref>). Based on these calculations, it was determined that 16 subjects per group would be sufficient to provide a power of 80% with an α of 0.05. A dropout rate of 10% was considered acceptable, therefore we aimed to recruit at least 35 patients. The Cohen's d was also calculated post hoc for the between‐group change in PIPD after treatment to evaluate the effect size. A commonly used interpretation suggested by Cohen is to categorize the effect sizes as small (d = 0.2), medium (d = 0.5), and large (d = 0.8) (Lakens, <xref rid="clr13914-bib-0015" ref-type="bibr">2013</xref>).</p>
                <p>The primary outcome parameter was the change in PIPD from baseline to 12 weeks, while secondary outcomes included BoP, SoP, and PI. Analysis was performed at one target site per patient. Descriptive statistics included mean ± SD and percentages (%) for numerical and categorical variables, respectively, and were reported at patient level. The Shapiro–Wilk test was used to assess the normality of data distribution. Independent samples <italic toggle="yes">t</italic>‐test and paired <italic toggle="yes">t</italic>‐test were used to analyze inter‐group and intra‐group differences, respectively, for continuous data. The Chi‐squared test or Fisher's exact test was used for inter‐group differences in categorical variables. Intra‐group comparisons of categorical variables were performed using the McNemar's Chi‐squared test. The SPSS version 19.00 software (SPSS Inc., Chicago, IL, USA) was used for all analyses. The level of significance was set at <italic toggle="yes">p</italic> &lt; 0.05.</p>
                <p>In order to explore whether the prescribed antimicrobials have an effect on PIPD reduction after controlling for potential confounding factors, we applied a linear mixed model (LMM) with random intercept and random slope including baseline PIPD and antibiotics usage (yes/no) as fixed factors (Model 0) (R 4.0.4, <ext-link xlink:href="http://www.r-project.org" ext-link-type="uri">www.r‐project.org</ext-link>). Age, sex (m/f), body mass index (BMI), smoking (yes/no), history of periodontitis (yes/no), presence of natural teeth (yes/no), number of implants, type of prosthesis (screw retained/cement retained), number of sites with SoP at baseline, full mouth plaque score at baseline, and implant brand (Straumann, Nobel, BioMet 3i or other) were evaluated as potential confounders. Each of the aforementioned factors was first individually screened in Model 0. Any factor that showed a <italic toggle="yes">p</italic>‐value of &lt;.1 in these screening models was to be included in the final LMM model as confounder.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="clr13914-sec-0013">
              <label>3</label>
              <title>RESULTS</title>
              <sec id="clr13914-sec-0014">
                <label>3.1</label>
                <title>Patient characteristics</title>
                <p>Of the 43 patients screened, 37 were found eligible and were randomized to the experimental (<italic toggle="yes">n</italic> = 18) or to the control group (<italic toggle="yes">n</italic> = 19) (Figure <xref rid="clr13914-fig-0001" ref-type="fig">1</xref>). All randomized patients completed the study and were included in the analysis. The characteristics of the participants are presented in Table <xref rid="clr13914-tbl-0001" ref-type="table">1</xref>. The majority of patients (65%) were female. Age ranged from 25 to 84 years, mean 59.6 ± 11.2 years. Regarding smoking habits, 11 patients (30%) were smokers, and 26 patients (70%) were non‐smokers at the time of the study. The majority of the participants had no history of periodontitis (<italic toggle="yes">n</italic> = 21, 57%), however, the majority of dentate patients included in the study (<italic toggle="yes">n</italic> = 24, 83%) appeared periodontally non stable. Most implants were placed in the mandible (60%) and in the posterior region (54%). The baseline characteristics of the included implants are presented in Table <xref rid="clr13914-tbl-0002" ref-type="table">2</xref>. The two groups were comparable in terms of baseline demographic and implant characteristics.</p>
                <table-wrap position="float" id="clr13914-tbl-0001" content-type="TABLE">
                  <label>TABLE 1</label>
                  <caption>
                    <p>Study population characteristics at baseline</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Variable</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">NST (<italic toggle="yes">n</italic> = 19)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">NST with AMX + MTZ (<italic toggle="yes">n</italic> = 18)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">
                          <p>Test statistic,</p>
                          <p><italic toggle="yes">p</italic>‐value</p>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, mean ± SD (range), years</td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>60.8 ± 14.8</p>
                          <p>(25–84)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>58.3 ± 13.9</p>
                          <p>(27–79)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">T = 0.532, <italic toggle="yes">p </italic>= 0.598<xref rid="clr13914-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sex, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 0.217, <italic toggle="yes">p</italic> = 0.737<xref rid="clr13914-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td>
                        <td align="left" rowspan="1" colspan="1">6 (32%)</td>
                        <td align="left" rowspan="1" colspan="1">7 (39%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td>
                        <td align="left" rowspan="1" colspan="1">13 (68%)</td>
                        <td align="left" rowspan="1" colspan="1">11 (61%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Smoking status, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 3.633, <italic toggle="yes">p</italic> = 0.056<xref rid="clr13914-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Smoker</td>
                        <td align="left" rowspan="1" colspan="1">3 (16%)</td>
                        <td align="left" rowspan="1" colspan="1">8 (44%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Non‐smoker</td>
                        <td align="left" rowspan="1" colspan="1">16 (84%)</td>
                        <td align="left" rowspan="1" colspan="1">10 (56%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI, mean ± SD (range), kg/m<sup>2</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>25.3 ± 4.0</p>
                          <p>(19.6–34.1)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>23.3 ± 2.8</p>
                          <p>(18.5–28.7)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">T = 1.764, <italic toggle="yes">p</italic> = 0.087<xref rid="clr13914-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Dental status, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">
                          <p>Fisher's exact test,</p>
                          <p><italic toggle="yes">p </italic>= 1.000</p>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Fully edentulous</td>
                        <td align="left" rowspan="1" colspan="1">4 (21%)</td>
                        <td align="left" rowspan="1" colspan="1">4 (22%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Partially edentulous</td>
                        <td align="left" rowspan="1" colspan="1">15 (79%)</td>
                        <td align="left" rowspan="1" colspan="1">14 (78%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of natural teeth in dentate patients, mean ± SD (range)</td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>21.3 ± 5.4</p>
                          <p>(10–28)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>21.8 ± 4.9</p>
                          <p>(10–27)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">T = 0.294, <italic toggle="yes">p </italic>= 0.770<xref rid="clr13914-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">History of periodontitis, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 0.652, <italic toggle="yes">p </italic>= 0.515<xref rid="clr13914-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">7 (37%)</td>
                        <td align="left" rowspan="1" colspan="1">9 (50%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">12 (63%)</td>
                        <td align="left" rowspan="1" colspan="1">9 (50%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"><xref rid="clr13914-note-0005" ref-type="table-fn"><sup>§</sup></xref>Periodontal stability, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">
                          <p>Fisher's exact test,</p>
                          <p><italic toggle="yes">p </italic>= 0.893</p>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">2 (13%)</td>
                        <td align="left" rowspan="1" colspan="1">3 (21%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">13 (87%)</td>
                        <td align="left" rowspan="1" colspan="1">11 (79%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
                          <p>FMPS %</p>
                          <p>mean ± SD (range)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>40 ± 27.3</p>
                          <p>(0–100)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <p>30.3 ± 28.1</p>
                          <p>(0–100)</p>
                        </td>
                        <td align="left" rowspan="1" colspan="1">T = 0.189, <italic toggle="yes">p </italic>= 0.851<xref rid="clr13914-note-0003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of implants, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 0.021, <italic toggle="yes">p </italic>= 0.886<xref rid="clr13914-note-0004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">≥4 implants</td>
                        <td align="left" rowspan="1" colspan="1">8 (42%)</td>
                        <td align="left" rowspan="1" colspan="1">8 (44%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&lt;4 implants</td>
                        <td align="left" rowspan="1" colspan="1">11 (58%)</td>
                        <td align="left" rowspan="1" colspan="1">10 (56%)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="clr13914-ntgp-0002">
                    <fn id="clr13914-note-0002">
                      <p>Abbreviations: AMX, Amoxicillin; BMI, Body mass index; FMPS, Full mouth plaque score; MTZ, Metronidazole; NST, Non‐surgical treatment; SD, Standard deviation.</p>
                    </fn>
                    <fn id="clr13914-note-0003">
                      <label>†</label>
                      <p>Independent sample t‐test.</p>
                    </fn>
                    <fn id="clr13914-note-0004">
                      <label>‡</label>
                      <p>Chi‐square test.</p>
                    </fn>
                    <fn id="clr13914-note-0005">
                      <label>§</label>
                      <p>Periodontal stability was evaluated in dentate patients.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <table-wrap position="float" id="clr13914-tbl-0002" content-type="TABLE">
                  <label>TABLE 2</label>
                  <caption>
                    <p>Implant characteristics at baseline</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Variable</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">NST (<italic toggle="yes">n</italic> = 19)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">NST with AMX + MTZ (<italic toggle="yes">n</italic> = 18)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">
                          <p>Test statistic,</p>
                          <p><italic toggle="yes">p</italic>‐value</p>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Implant location, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 0.040, <italic toggle="yes">p</italic> = 1.000<sup>‡</sup>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Maxilla</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8 (42%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">7 (39%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mandible</td>
                        <td align="char" char="(" rowspan="1" colspan="1">11 (58%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">11 (61%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Implant position, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 3.246, <italic toggle="yes">p</italic> = 0.103<sup>‡</sup>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anterior</td>
                        <td align="char" char="(" rowspan="1" colspan="1">6 (32%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">11 (61%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Posterior</td>
                        <td align="char" char="(" rowspan="1" colspan="1">13 (68%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">7 (39%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Type of connection, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="3" colspan="1">X<sup>2</sup> = 0.232, <italic toggle="yes">p</italic> = 0.630<sup>‡</sup>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Screw retained</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8 (42%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">9 (50%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cement retained</td>
                        <td align="char" char="(" rowspan="1" colspan="1">11 (58%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">9 (50%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Implant brand, <italic toggle="yes">n</italic> (%)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="5" colspan="1">X<sup>2</sup> = 3.896, <italic toggle="yes">p</italic> = 0.272<sup>‡</sup>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Nobel</td>
                        <td align="char" char="(" rowspan="1" colspan="1">5 (26%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">9 (50%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Straumann</td>
                        <td align="char" char="(" rowspan="1" colspan="1">5 (26%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">4 (22%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Biomet 3i</td>
                        <td align="char" char="(" rowspan="1" colspan="1">5 (26%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">1 (6%)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other</td>
                        <td align="char" char="(" rowspan="1" colspan="1">4 (21%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">4 (22%)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="clr13914-ntgp-0003">
                    <fn id="clr13914-note-0006">
                      <p>Abbreviations: AMX, Amoxicillin; MTZ, Metronidazole; NST, Non‐surgical treatment.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="clr13914-sec-0015">
                <label>3.2</label>
                <title>Clinical outcomes</title>
                <p>None of the patients reported side effects associated with the use of antibiotics or the clinical procedures performed in the study. The clinical parameters at baseline and at 12 weeks are presented in Figures <xref rid="clr13914-fig-0002" ref-type="fig">2</xref> and <xref rid="clr13914-fig-0003" ref-type="fig">3</xref> and in Table <xref rid="clr13914-sup-0001" ref-type="supplementary-material">S1</xref>. At baseline, all clinical parameters were comparable in both groups. At 12 weeks, both treatment modalities resulted in improvements in clinical parameters. After NST alone, the mean PIPD of the target sites changed from 8.00 ± 1.41 mm at baseline to 6.53 ± 2.59 mm at 12 weeks (<italic toggle="yes">p</italic> = .004). After NST with the addition of antibiotics, the mean PIPD of the target sites changed from 7.44 ± 1.38 mm at baseline to 5.17 ± 1.92 mm at 12 weeks (<italic toggle="yes">p</italic> &lt; .001). Regarding the secondary outcomes, intra‐group analysis showed that none of the two groups achieved statistically significant reduction in BoP of target sites. Nevertheless, for both groups, the target sites showed a statistically significant reduction in SoP at 12 weeks (<italic toggle="yes">p</italic> &lt; .01). Although plaque was reduced at follow‐up for both groups, only in the control group a statistically significant reduction in target sites with plaque was observed (<italic toggle="yes">p</italic> &lt; .05). At 12 weeks, none of the clinical parameters were significantly different between the two groups.</p>
                <fig position="float" fig-type="FIGURE" id="clr13914-fig-0002">
                  <label>FIGURE 2</label>
                  <caption>
                    <p>The histograms illustrate the peri‐implant probing depth (PIPD) at target site. (a) Mean PIPD at baseline and at 12 weeks, (b) mean change in PIPD between baseline and 12 weeks for the control and experimental group. There were no inter‐group differences. The asterisks (**<italic toggle="yes">p</italic> &lt; .01 and ***; <italic toggle="yes">p</italic> &lt; .001) represent statistically significant intra‐group differences from baseline to 12 weeks. Error bars: 95% confidence interval</p>
                  </caption>
                  <graphic xlink:href="CLR-33-548-g001" position="anchor" id="jats-graphic-3"/>
                </fig>
                <fig position="float" fig-type="FIGURE" id="clr13914-fig-0003">
                  <label>FIGURE 3</label>
                  <caption>
                    <p>The bar graphs illustrate the frequencies of the secondary outcome parameters (a) bleeding on probing (BoP), (b) suppuration on probing (SoP), and (c) plaque at target site level for the control and the experimental group at baseline and at 12 weeks. The data are expressed as percentage (%) of target sites which present BoP, SoP and plaque respectively. The asterisks (*; <italic toggle="yes">p</italic> &lt; .05 and **; <italic toggle="yes">p</italic> &lt; .001) represent statistically significant intra‐group differences from baseline to 12 weeks</p>
                  </caption>
                  <graphic xlink:href="CLR-33-548-g002" position="anchor" id="jats-graphic-5"/>
                </fig>
                <p>When the change (Δ) in PIPD from baseline to 12 weeks was evaluated, the experimental group showed a larger mean PIPD reduction of 2.28 ± 1.49 mm, as compared to 1.47 ± 1.95 mm in the control group. Nevertheless, the difference in mean PIPD reduction between the two groups did not reach statistical significance (<italic toggle="yes">p</italic> = .170). The Cohen's d effect size for the between‐group change in PIPD was found to be 0.466, suggesting a medium‐effect size.</p>
                <p>Clinical outcomes according to baseline PIPD of all six peri‐implant sites are displayed in Table <xref rid="clr13914-tbl-0003" ref-type="table">3</xref>. At baseline, approximately half (54%) of the participants presented with PIPD ≥8 mm, 41% presented with PIPD ≥9 mm, and 8% presented with PIPD ≥10 mm. NST with antibiotics resulted in a statistically significant reduction in the frequency of patients with baseline PIPDs ≥6 mm and ≥7 mm at 12 weeks, as compared to baseline. At 12 weeks, 16 patients (84%) of the control group and 14 patients (78%) of the experimental group had residual PIPDs ≥5 mm. Nevertheless, there were no statistically significant differences in the distribution of sites with different PIPDs between control and experimental group neither at baseline nor at the re‐evaluation.</p>
                <table-wrap position="float" id="clr13914-tbl-0003" content-type="TABLE">
                  <label>TABLE 3</label>
                  <caption>
                    <p>Clinical outcomes according to baseline PIPD of all six peri‐implant sites</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1"/>
                        <th align="left" valign="top" rowspan="1" colspan="1">NST (<italic toggle="yes">n</italic> = 19)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">NST with AMX + MTZ (<italic toggle="yes">n</italic> = 18)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Between‐group test statistic, <italic toggle="yes">p</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">PIPD ≥5 mm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" char="(" rowspan="1" colspan="1">19 (100%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">18 (100%)</td>
                        <td align="left" rowspan="1" colspan="1">N/A</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Week 12</td>
                        <td align="char" char="(" rowspan="1" colspan="1">16 (84%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">14 (78%)</td>
                        <td align="left" rowspan="1" colspan="1">Fisher's exact test, <italic toggle="yes">p </italic>= 0.693</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">PIPD ≥6 mm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" char="(" rowspan="1" colspan="1">19 (100%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">16 (89%)</td>
                        <td align="left" rowspan="1" colspan="1">Fisher's exact test, <italic toggle="yes">p </italic>= 0.230</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Week 12</td>
                        <td align="char" char="(" rowspan="1" colspan="1">14 (74%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8 (44%)<xref rid="clr13914-note-0009" ref-type="table-fn">*</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">X<sup>2</sup> = 3.278, <italic toggle="yes">p </italic>= 0.070</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">PIPD ≥7 mm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" char="(" rowspan="1" colspan="1">15 (79%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">12 (67%)</td>
                        <td align="left" rowspan="1" colspan="1">Fisher's exact test, 0.476</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Week 12</td>
                        <td align="char" char="(" rowspan="1" colspan="1">10 (53%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">4 (22%)<xref rid="clr13914-note-0009" ref-type="table-fn">*</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">X<sup>2</sup> = 3.278, <italic toggle="yes">p </italic>= 0.057</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">PIPD ≥8 mm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" char="(" rowspan="1" colspan="1">11 (58%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">9 (50%)</td>
                        <td align="left" rowspan="1" colspan="1">X<sup>2</sup> = 0.232, <italic toggle="yes">p </italic>= 0.630</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Week 12</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8 (42%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">4 (22%)</td>
                        <td align="left" rowspan="1" colspan="1">X<sup>2</sup> = 1.668, <italic toggle="yes">p </italic>= 0.197</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">PIPD ≥9 mm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" char="(" rowspan="1" colspan="1">9 (47%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">6 (33%)</td>
                        <td align="left" rowspan="1" colspan="1">X<sup>2</sup> = 0.755, <italic toggle="yes">p </italic>= 0.385</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Week 12</td>
                        <td align="char" char="(" rowspan="1" colspan="1">7 (37%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">3 (17%)</td>
                        <td align="left" rowspan="1" colspan="1">Fisher's exact test, <italic toggle="yes">p </italic>= 0.269</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">PIPD ≥10 mm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" char="(" rowspan="1" colspan="1">2 (11%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">1 (6%)</td>
                        <td align="left" rowspan="1" colspan="1">Fisher's exact test, <italic toggle="yes">p </italic>= 1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Week 12</td>
                        <td align="char" char="(" rowspan="1" colspan="1">2 (11%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">1 (6%)</td>
                        <td align="left" rowspan="1" colspan="1">Fisher's exact test, <italic toggle="yes">p </italic>= 1.000</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="clr13914-ntgp-0004">
                    <title>Note</title>
                    <fn id="clr13914-note-0007">
                      <p>The values represent frequency of patients (<italic toggle="yes">n</italic>, %) having PIPD ≥5, ≥6, ≥7, ≥8, ≥9, and ≥10 mm at baseline and at 12 weeks, for the experimental group and for the control group.</p>
                    </fn>
                    <fn id="clr13914-note-0008">
                      <p>Abbreviations: AMX, Amoxicillin; MTZ, Metronidazole; NST, Non‐surgical treatment; PIPD, Peri‐implant pocket depth.</p>
                    </fn>
                    <fn id="clr13914-note-0009">
                      <label>*</label>
                      <p>Significant difference between baseline and 12 weeks (<italic toggle="yes">p</italic> &lt; .01). McNemar's Chi‐square test.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>Regarding treatment success at the 12‐week follow‐up, only three target sites in the control group and two target sites in the experimental group were treated successfully (<italic toggle="yes">p</italic> = 1.000), with complete absence of BoP and SoP. Considering all six sites around the target implant, two implants (e.g., two patients), one in each group, exhibited a successful outcome.</p>
                <p>Of all the factors examined as potential confounders (including age, sex, BMI, smoking, history of periodontitis, presence of natural teeth, number of implants, type of prosthesis, number of sites with SoP, full mouth plaque score, and implant brand), none was identified as significant confounder with <italic toggle="yes">p</italic>‐value &lt; .1 in the initial LMM. Therefore, the final model remained Model 0 including baseline PIPD and antibiotics usage as fixed factors, without any confounders (Table <xref rid="clr13914-sup-0001" ref-type="supplementary-material">S2</xref>). From this model, the adjusted PIPD reduction in the experimental group is 0.80 mm larger than that in the control group, however, without reaching statistical significance (<italic toggle="yes">adjusted p</italic>‐value = .169).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="clr13914-sec-0016">
              <label>4</label>
              <title>DISCUSSION</title>
              <p>In the present study, the change in PIPD was the primary outcome. It has been demonstrated that PIPD determines the microbial ecology of the peri‐implant site, with deep pockets favoring the outgrowth of Gram‐negative anaerobic species, which are compatible with peri‐implant disease (Mombelli &amp; Decaillet, <xref rid="clr13914-bib-0022" ref-type="bibr">2011</xref>). This is based on the knowledge about the microbial communities in deep periodontitis lesions (Hajishengallis &amp; Lamont, <xref rid="clr13914-bib-0010" ref-type="bibr">2021</xref>). According to the results of the present study, a reduction in mean PIPD following NST plus administration of AMX and MTZ was observed after 12 weeks (mean 2.28 mm) which was greater than NST alone (mean 1.47 mm), although not reaching statistical significance. The current results are in accordance with three recent studies, one cohort and two RCTs, which evaluated the use of systemic AMX and MTZ as an adjunct in the NST of PI (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>; Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>; Stein et al., <xref rid="clr13914-bib-0038" ref-type="bibr">2018</xref>). These studies reported that both NST alone and NST with antibiotics led to PIPD reduction ranging from 0.40 to 1.67 mm at 3 months (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>) and 12 months (Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>; Stein et al., <xref rid="clr13914-bib-0038" ref-type="bibr">2018</xref>). Taken together, from the current study and three previous studies, it seems not justified to prescribe systemic AMX and MTZ in the NST of PI. On the other hand, an RCT where systemic MTZ was prescribed for 7 days reported a mean reduction in PIPD of 2.53 mm in the experimental group versus 1.02 mm in the placebo group (<italic toggle="yes">p</italic> &lt; .05) after 12 months (Blanco et al., <xref rid="clr13914-bib-0003" ref-type="bibr">2022</xref>). That reduction in PIPD was also accompanied by a mean reduction of 2.33 mm in the intra‐bony component of the peri‐implant defect in the experimental group, as compared with 1.13 mm in the placebo group (<italic toggle="yes">p</italic> &lt; .05). The latter study, however, included re‐contouring of the prostheses where needed in order to facilitate oral hygiene. Furthermore, the implant‐supported restorations were removed if possible during NST (Blanco et al., <xref rid="clr13914-bib-0003" ref-type="bibr">2022</xref>).</p>
              <p>In the present study, the success rate was very low; only three target sites in the control group and two target sites in the experimental group (or one patient in each group) showed complete resolution of the disease (PIPD &lt;5 mm, no BoP and/or SoP). This could be attributed to the fact that 81% of the target sites still had BoP after treatment. Similar results in BoP reduction at 12 weeks after treatment were reported by Shibli et al., even though BoP further decreased at the 1 year follow‐up (mean BoP 40.3% and 35.6% at control and experimental group, respectively) (Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>). In any case, all previous studies and the current study agree that NST (with or without antimicrobials) is ineffective to completely resolve BoP around dental implants (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>; Nart et al., <xref rid="clr13914-bib-0025" ref-type="bibr">2020</xref>; Stein et al., <xref rid="clr13914-bib-0038" ref-type="bibr">2018</xref>). Factors that might account for the low success rates of NST for PI could be related to the inherent difficulties in removing the biofilm from the implant surfaces, to the type of instruments used to perform the debridement (ultrasonic and hand instruments vs. air‐abrasive devices), and to the fact that no removal and cleaning or modification of the suprastructure was performed in conjunction with NST (de Avila et al., <xref rid="clr13914-bib-0005" ref-type="bibr">2020</xref>; Ronay et al., <xref rid="clr13914-bib-0035" ref-type="bibr">2017</xref>). Perhaps a more strict monitoring of the patients during the study period (e.g., a biweekly hygiene check) could have resulted in more favorable outcomes in terms of inflammatory parameters (Machtei et al., <xref rid="clr13914-bib-0021" ref-type="bibr">2021</xref>), but practically it is not easily applicable to a regular dental office.</p>
              <p>This study had several limitations; first, the presence of potential local etiological factors including implant positioning, excess cement, presence of keratinized attached gingiva (Monje et al., <xref rid="clr13914-bib-0024" ref-type="bibr">2019</xref>), to name a few, was not evaluated. Second, 54% of the patients included in this study were presented with deep PIPD ≥8 mm. The low success rate observed in this study supports previous literature reports that in severe PI cases non‐surgical treatment alone is insufficient to arrest the disease and eliminate bacteria from the rough surfaces of implants and from the concavities between implant threads (Faggion Jr et al., <xref rid="clr13914-bib-0007" ref-type="bibr">2013</xref>; Persson et al., <xref rid="clr13914-bib-0027" ref-type="bibr">2010</xref>; Renvert et al., <xref rid="clr13914-bib-0032" ref-type="bibr">2019</xref>). Therefore, severe PI maybe best treated by NST first, followed by surgical therapy (Renvert et al., <xref rid="clr13914-bib-0034" ref-type="bibr">2012</xref>). Third, the follow‐up period was rather short, however, it was not considered appropriate to delay further treatment for the cases with residual inflamed deep PIPDs. Thus, the long‐term effect of the current NST modality, on implant survival and prevention of further progression of PI, for example, could not be evaluated. Finally, although an a priori power analysis was performed based on a mean difference in PIPD after treatment of 1 mm between the experimental and control group with standard deviation of 1 mm, the actual difference in PIPD reduction between the two groups was smaller than expected (0.81 mm) and the standard deviation was 1.95 mm, almost double than the one used in the power analysis. Also, we found the effect size of change in PIPD to be moderate. This indicates that the study was underpowered and we cannot rule out that with an increased number of patients the power of the study would have increased and with that a small adjunctive, statistically significant effect of antibiotics would have been found. Nevertheless, whether such statistically significant effect would be clinically relevant needs to be seen.</p>
              <p>The existing data regarding the benefits of use of systemic antibiotics on the microbiological parameters of the patients are contradictory. Two recent RCTs, which evaluated the submucosal peri‐implant biofilm profiles using targeted techniques after NST with or without the combination of systemically administered AMX and MTZ, did not find any beneficial microbiological effects with the use of antibiotics (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>; Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>). Both studies reported that at follow‐up (1 year and 3 months, respectively), many implants had become recolonized with periodontal pathogens, and that there were no statistically significant differences between control and experimental groups (De Waal et al., <xref rid="clr13914-bib-0006" ref-type="bibr">2021</xref>; Shibli &amp; Ferrari, <xref rid="clr13914-bib-0036" ref-type="bibr">2019</xref>). On the other hand, (Blanco et al., <xref rid="clr13914-bib-0003" ref-type="bibr">2022</xref>) reported a significantly greater decrease in the counts of <italic toggle="yes">Porphyromonas gingivalis</italic>, <italic toggle="yes">Tannerella forsythia</italic>, and <italic toggle="yes">Campylobacter rectus</italic> at 12 months in patients receiving systemic MTZ compared with the control group (Blanco et al., <xref rid="clr13914-bib-0003" ref-type="bibr">2022</xref>). That being said, when prescribing systemic antibiotics for the treatment of PI, we should take into consideration the potential side‐effects (Heta &amp; Robo, <xref rid="clr13914-bib-0013" ref-type="bibr">2018</xref>), the risk of superinfection with opportunistic bacteria, yeast, and viruses, which may be difficult to eradicate (Verdugo, <xref rid="clr13914-bib-0040" ref-type="bibr">2018</xref>), the development of bacterial resistance (Rams et al., <xref rid="clr13914-bib-0031" ref-type="bibr">2014</xref>), and the frequent need for surgery anyway to further treat residual PIPD (Faggion Jr et al., <xref rid="clr13914-bib-0007" ref-type="bibr">2013</xref>; Renvert et al., <xref rid="clr13914-bib-0032" ref-type="bibr">2019</xref>). Therefore, the decision to administer adjunctive systemic antibiotics should be made with caution, and the practitioner should consider the medical history of the patient, concomitant medications, and the ultimate goal of the treatment (i.e., shallow residual pockets around the implant where PI was present).</p>
              <p>In conclusion, the present study showed no clinical benefit from the adjunctive use of systemic AMX and MTZ in the NST of PI. We suggest that the routine use of systemic antibiotics in NST of PI is not recommended. Furthermore, neither of the tested treatment modalities achieved complete resolution of the disease. Although NST should always be the first step in PI treatment, which provides some improvement in clinical parameters and allows for oral hygiene improvement and better patient compliance, sufficient PIPD reduction in severe PI cases can only be accomplished after a surgical treatment phase.</p>
            </sec>
            <sec sec-type="COI-statement" id="clr13914-sec-0018">
              <title>CONFLICT OF INTEREST</title>
              <p>The authors declare that there are no conflicts of interest in this study.</p>
            </sec>
            <sec id="clr13914-sec-0019">
              <title>AUTHOR CONTRIBUTION</title>
              <p><bold>Angeliki Polymeri:</bold> Formal analysis (lead); Investigation (supporting); Validation (equal); Visualization (lead); Writing – original draft (lead); Writing – review &amp; editing (equal). <bold>Joyce van der Horst:</bold> Investigation (lead); Methodology (equal); Writing – review &amp; editing (equal). <bold>David Anssari‐Moin:</bold> Data curation (supporting); Investigation (lead); Methodology (equal); Writing – review &amp; editing (equal). <bold>Daniel Wismeijer:</bold> Conceptualization (equal); Methodology (equal); Resources (equal); Validation (equal); Writing – review &amp; editing (equal). <bold>Bruno G. Loos:</bold> Conceptualization (equal); Formal analysis (supporting); Funding acquisition (equal); Methodology (equal); Project administration (equal); Resources (equal); Supervision (equal); Validation (equal); Visualization (supporting); Writing – review &amp; editing (equal). <bold>Marja L. Laine:</bold> Conceptualization (equal); Data curation (lead); Formal analysis (supporting); Funding acquisition (equal); Methodology (equal); Project administration (equal); Supervision (equal); Validation (equal); Visualization (supporting); Writing – review &amp; editing (equal).</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="clr13914-sup-0001" position="float" content-type="local-data">
                <caption>
                  <p>Table S1‐S2</p>
                </caption>
                <media xlink:href="CLR-33-548-s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="clr13914-sup-0002" position="float" content-type="local-data">
                <caption>
                  <p>Supplementary Material</p>
                </caption>
                <media xlink:href="CLR-33-548-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="clr13914-sec-0017">
              <title>ACKNOWLEDGMENT</title>
              <p>The authors thank Dr. N. Su, Department of Oral Public Health, ACTA, for his help in the statistical modeling of the data.</p>
            </ack>
            <sec sec-type="data-availability" id="clr13914-sec-0021">
              <title>DATA AVAILABILITY STATEMENT</title>
              <p>The data that support the results of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p>
            </sec>
            <ref-list content-type="cited-references" id="clr13914-bibl-0001">
              <title>REFERENCES</title>
              <ref id="clr13914-bib-0001">
                <mixed-citation publication-type="journal" id="clr13914-cit-0001"><string-name><surname>Berglundh</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Krok</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Liljenberg</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Westfelt</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Serino</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Lindhe</surname>, <given-names>J.</given-names></string-name> (<year>1998</year>). <article-title>The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>25</volume>(<issue>5</issue>), <fpage>354</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.1998.tb02455.x</pub-id>
<pub-id pub-id-type="pmid">9650870</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0002">
                <mixed-citation publication-type="journal" id="clr13914-cit-0002"><string-name><surname>Berglundh</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Zitzmann</surname>, <given-names>N. U.</given-names></string-name>, &amp; <string-name><surname>Donati</surname>, <given-names>M.</given-names></string-name> (<year>2011</year>). <article-title>Are peri‐implantitis lesions different from periodontitis lesions?</article-title>
<source>Journal of Clinical Periodontology</source>, <volume>38</volume>(<issue>s11</issue>), <fpage>188</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2010.01672.x</pub-id>
<pub-id pub-id-type="pmid">21323715</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0003">
                <mixed-citation publication-type="journal" id="clr13914-cit-0003"><string-name><surname>Blanco</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Pico</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Dopico</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gándara</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Blanco</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Liñares</surname>, <given-names>A.</given-names></string-name> (<year>2022</year>). <article-title>Adjunctive benefits of systemic metronidazole on non‐surgical treatment of peri‐implantitis. A randomized placebo‐controlled clinical trial</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>49</volume>(<issue>1</issue>), <fpage>15</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.13564</pub-id>
<pub-id pub-id-type="pmid">34713471</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0004">
                <mixed-citation publication-type="journal" id="clr13914-cit-0004"><string-name><surname>Chapple</surname>, <given-names>I. L. C.</given-names></string-name>, <string-name><surname>Mealey</surname>, <given-names>B. L.</given-names></string-name>, <string-name><surname>Van Dyke</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Bartold</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Dommisch</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Eickholz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Geisinger</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Genco</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Glogauer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Goldstein</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Griffin</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Holmstrup</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>G. K.</given-names></string-name>, <string-name><surname>Kapila</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lang</surname>, <given-names>N. P.</given-names></string-name>, <string-name><surname>Meyle</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Murakami</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Plemons</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Romito</surname>, <given-names>G. A.</given-names></string-name>, … <string-name><surname>Yoshie</surname>, <given-names>H.</given-names></string-name> (<year>2018</year>). <article-title>Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>45</volume>(<issue>S20</issue>), <fpage>S68</fpage>–<lpage>S77</lpage>.<pub-id pub-id-type="pmid">29926499</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0005">
                <mixed-citation publication-type="journal" id="clr13914-cit-0005"><string-name><surname>de Avila</surname>, <given-names>E. D.</given-names></string-name>, <string-name><surname>van Oirschot</surname>, <given-names>B. A.</given-names></string-name>, &amp; <string-name><surname>van den Beucken</surname>, <given-names>J. J. J. P.</given-names></string-name> (<year>2020</year>). <article-title>Biomaterial‐based possibilities for managing peri‐implantitis</article-title>. <source>Journal of Periodontal Research</source>, <volume>55</volume>(<issue>2</issue>), <fpage>165</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1111/jre.12707</pub-id>
<pub-id pub-id-type="pmid">31638267</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0006">
                <mixed-citation publication-type="journal" id="clr13914-cit-0006"><string-name><surname>De Waal</surname>, <given-names>Y. C. M.</given-names></string-name>, <string-name><surname>Vangsted</surname>, <given-names>T. E.</given-names></string-name>, &amp; <string-name><surname>Van Winkelhoff</surname>, <given-names>A. J.</given-names></string-name> (<year>2021</year>). <article-title>Systemic antibiotic therapy as an adjunct to non‐surgical peri‐implantitis treatment: A single‐blind RCT</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>48</volume>(<issue>7</issue>), <fpage>996</fpage>–<lpage>1006</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.13464</pub-id>
<pub-id pub-id-type="pmid">33939193</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0007">
                <mixed-citation publication-type="journal" id="clr13914-cit-0007"><string-name><surname>Faggion</surname>, <given-names>C. M.</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Chambrone</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Listl</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Tu</surname>, <given-names>Y.‐K.</given-names></string-name> (<year>2013</year>). <article-title>Network meta‐analysis for evaluating interventions in implant dentistry: the case of peri‐implantitis treatment</article-title>. <source>Clinical Implant Dentistry and Related Research</source>, <volume>15</volume>(<issue>4</issue>), <fpage>576</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1111/j.1708-8208.2011.00384.x</pub-id>
<pub-id pub-id-type="pmid">21834862</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0008">
                <mixed-citation publication-type="journal" id="clr13914-cit-0008"><string-name><surname>Garaicoa‐Pazmino</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Sinjab</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Wang</surname>, <given-names>H.‐L.</given-names></string-name> (<year>2019</year>). <article-title>Current protocols for the treatment of peri‐implantitis</article-title>. <source>Current Oral Health Reports</source>, <volume>6</volume>(<issue>3</issue>), <fpage>209</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1007/s40496-019-00227-4</pub-id>
</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0009">
                <mixed-citation publication-type="journal" id="clr13914-cit-0009"><string-name><surname>Hajishengallis</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Chavakis</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Lambris</surname>, <given-names>J. D.</given-names></string-name> (<year>2020</year>). <article-title>Current understanding of periodontal disease pathogenesis and targets for host‐modulation therapy</article-title>. <source>Periodontology 2000</source>, <volume>84</volume>(<issue>1</issue>), <fpage>14</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12331</pub-id>
<pub-id pub-id-type="pmid">32844416</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0010">
                <mixed-citation publication-type="journal" id="clr13914-cit-0010"><string-name><surname>Hajishengallis</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Lamont</surname>, <given-names>R. J.</given-names></string-name> (<year>2021</year>). <article-title>Polymicrobial communities in periodontal disease: Their quasi‐organismal nature and dialogue with the host</article-title>. <source>Periodontology 2000</source>, <volume>86</volume>(<issue>1</issue>), <fpage>210</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12371</pub-id>
<pub-id pub-id-type="pmid">33690950</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0011">
                <mixed-citation publication-type="journal" id="clr13914-cit-0011"><string-name><surname>Heitz‐Mayfield</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Lang</surname>, <given-names>N.</given-names></string-name> (<year>2004</year>). <article-title>Antimicrobial treatment of peri‐implant diseases</article-title>. <source>The International Journal of Oral &amp; Maxillofacial Implants</source>, <volume>19</volume>(<issue>Suppl</issue>), <fpage>128</fpage>–<lpage>139</lpage>.<pub-id pub-id-type="pmid">15635953</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0012">
                <mixed-citation publication-type="journal" id="clr13914-cit-0012"><string-name><surname>Heitz‐Mayfield</surname>, <given-names>L. J. A.</given-names></string-name>, <string-name><surname>Salvi</surname>, <given-names>G. E.</given-names></string-name>, <string-name><surname>Mombelli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Loup</surname>, <given-names>P.‐J.</given-names></string-name>, <string-name><surname>Heitz</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Kruger</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Lang</surname>, <given-names>N. P.</given-names></string-name> (<year>2018</year>). <article-title>Supportive peri‐implant therapy following anti‐infective surgical peri‐implantitis treatment: 5‐year survival and success</article-title>. <source>Clinical Oral Implants Research</source>, <volume>29</volume>(<issue>1</issue>), <fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/clr.12910</pub-id>
<pub-id pub-id-type="pmid">27335316</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0013">
                <mixed-citation publication-type="journal" id="clr13914-cit-0013"><string-name><surname>Heta</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Robo</surname>, <given-names>I.</given-names></string-name> (<year>2018</year>). <article-title>The side effects of the most commonly used group of antibiotics in periodontal treatments</article-title>. <source>Medical Sciences (Basel, Switzerland)</source>, <volume>6</volume>(<issue>1</issue>), <fpage>6</fpage>.</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0014">
                <mixed-citation publication-type="journal" id="clr13914-cit-0014"><string-name><surname>Lafaurie</surname>, <given-names>G. I.</given-names></string-name>, <string-name><surname>Sabogal</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Castillo</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Rincon</surname>, <given-names>M. V.</given-names></string-name>, <string-name><surname>Gomez</surname>, <given-names>L. A.</given-names></string-name>, <string-name><surname>Lesmes</surname>, <given-names>Y. A.</given-names></string-name>, &amp; <string-name><surname>Chambrone</surname>, <given-names>L.</given-names></string-name> (<year>2017</year>). <article-title>Microbiome and microbial biofilm profiles of peri‐implantitis: a systematic review</article-title>. <source>Journal of Periodontology</source>, <volume>88</volume>(<issue>10</issue>), <fpage>1066</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2017.170123</pub-id>
<pub-id pub-id-type="pmid">28625077</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0015">
                <mixed-citation publication-type="journal" id="clr13914-cit-0015"><string-name><surname>Lakens</surname>, <given-names>D.</given-names></string-name> (<year>2013</year>). <article-title>Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t‐tests and ANOVAs</article-title>. <source>Frontiers in Psychology</source>, <volume>4</volume>, <fpage>863</fpage>.<pub-id pub-id-type="pmid">24324449</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0017">
                <mixed-citation publication-type="journal" id="clr13914-cit-0017"><string-name><surname>Liñares</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Pico</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Blanco</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Blanco</surname>, <given-names>J.</given-names></string-name> (<year>2019</year>). <article-title>Adjunctive systemic metronidazole to nonsurgical therapy of peri‐implantitis with intrabony defects: a retrospective case series study</article-title>. <source>International Journal of Oral and Maxillofacial Implants</source>, <volume>34</volume>(<issue>5</issue>), <fpage>1237</fpage>–<lpage>1245</lpage>. <pub-id pub-id-type="doi">10.11607/jomi.7343</pub-id>
<pub-id pub-id-type="pmid">31528867</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0018">
                <mixed-citation publication-type="journal" id="clr13914-cit-0018"><string-name><surname>Lindhe</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Berglundh</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Ericsson</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Liljenberg</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name><surname>Marinello</surname>, <given-names>C.</given-names></string-name> (<year>1992</year>). <article-title>Experimental breakdown of peri‐implant and periodontal tissues. A study in the beagle dog</article-title>. <source>Clinical Oral Implants Research</source>, <volume>3</volume>(<issue>1</issue>), <fpage>9</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-0501.1992.030102.x</pub-id>
<pub-id pub-id-type="pmid">1420727</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0019">
                <mixed-citation publication-type="journal" id="clr13914-cit-0019"><string-name><surname>Lindhe</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Nyman</surname>, <given-names>S.</given-names></string-name> (<year>1984</year>). <article-title>Long‐term maintenance of patients treated for advanced periodontal disease</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>11</volume>(<issue>8</issue>), <fpage>504</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.1984.tb00902.x</pub-id>
<pub-id pub-id-type="pmid">6384275</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0020">
                <mixed-citation publication-type="journal" id="clr13914-cit-0020"><string-name><surname>Loos</surname>, <given-names>B. G.</given-names></string-name>, &amp; <string-name><surname>Van Dyke</surname>, <given-names>T. E.</given-names></string-name> (<year>2020</year>). <article-title>The role of inflammation and genetics in periodontal disease</article-title>. <source>Periodontology 2000</source>, <volume>83</volume>(<issue>1</issue>), <fpage>26</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12297</pub-id>
<pub-id pub-id-type="pmid">32385877</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0021">
                <mixed-citation publication-type="journal" id="clr13914-cit-0021"><string-name><surname>Machtei</surname>, <given-names>E. E.</given-names></string-name>, <string-name><surname>Romanos</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kang</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Travan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schmidt</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Papathanasiou</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tatarakis</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Tandlich</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Liberman</surname>, <given-names>L. H.</given-names></string-name>, <string-name><surname>Horwitz</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bassir</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Myneni</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shiau</surname>, <given-names>H. J.</given-names></string-name>, <string-name><surname>Shapira</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Donos</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Papas</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Meyle</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Giannobile</surname>, <given-names>W. V.</given-names></string-name>, <string-name><surname>Papapanou</surname>, <given-names>P. N.</given-names></string-name>, &amp; <string-name><surname>Kim</surname>, <given-names>D. M.</given-names></string-name> (<year>2021</year>). <article-title>Repeated delivery of chlorhexidine chips for the treatment of peri‐implantitis: A multicenter, randomized, comparative clinical trial</article-title>. <source>Journal of Periodontology</source>, <volume>92</volume>(<issue>1</issue>), <fpage>11</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/JPER.20-0353</pub-id>
</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0022">
                <mixed-citation publication-type="journal" id="clr13914-cit-0022"><string-name><surname>Mombelli</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Decaillet</surname>, <given-names>F.</given-names></string-name> (<year>2011</year>). <article-title>The characteristics of biofilms in peri‐implant disease</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>38</volume>(<issue>Suppl 11</issue>), <fpage>203</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">21323716</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0023">
                <mixed-citation publication-type="journal" id="clr13914-cit-0023"><string-name><surname>Mombelli</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Lang</surname>, <given-names>N. P.</given-names></string-name> (<year>1992</year>). <article-title>Antimicrobial treatment of peri‐implant infections</article-title>. <source>Clinical Oral Implants Research</source>, <volume>3</volume>(<issue>4</issue>), <fpage>162</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-0501.1992.030402.x</pub-id>
<pub-id pub-id-type="pmid">1298430</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0024">
                <mixed-citation publication-type="journal" id="clr13914-cit-0024"><string-name><surname>Monje</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Insua</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Wang</surname>, <given-names>H. L.</given-names></string-name> (<year>2019</year>). <article-title>Understanding peri‐implantitis as a plaque‐associated and site‐specific entity: on the local predisposing factors</article-title>. <source>Journal of Clinical Medicine</source>, <volume>8</volume>(<issue>2</issue>), <fpage>279</fpage>. <pub-id pub-id-type="doi">10.3390/jcm8020279</pub-id>
</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0025">
                <mixed-citation publication-type="journal" id="clr13914-cit-0025"><string-name><surname>Nart</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Pons</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Valles</surname>, <given-names>C.</given-names></string-name> (<year>2020</year>). <article-title>Non‐surgical therapeutic outcomes of peri‐implantitis: 12‐month results</article-title>. <source>Clinical Oral Investigations</source>, <volume>24</volume>(<issue>2</issue>), <fpage>675</fpage>–<lpage>682</lpage>.<pub-id pub-id-type="pmid">31123873</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0026">
                <mixed-citation publication-type="journal" id="clr13914-cit-0026"><string-name><surname>Papapanou</surname>, <given-names>P. N.</given-names></string-name>, <string-name><surname>Sanz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Buduneli</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Dietrich</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Feres</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fine</surname>, <given-names>D. H.</given-names></string-name>, <string-name><surname>Flemmig</surname>, <given-names>T. F.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Giannobile</surname>, <given-names>W. V.</given-names></string-name>, <string-name><surname>Graziani</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Greenwell</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Herrera</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kao</surname>, <given-names>R. T.</given-names></string-name>, <string-name><surname>Kebschull</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kinane</surname>, <given-names>D. F.</given-names></string-name>, <string-name><surname>Kirkwood</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Kocher</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kornman</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>P. S.</given-names></string-name>, … <string-name><surname>Tonetti</surname>, <given-names>M. S.</given-names></string-name> (<year>2018</year>). <article-title>Periodontitis: Consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri‐implant diseases and conditions</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>45</volume>(<issue>S20</issue>), <fpage>S162</fpage>–<lpage>S170</lpage>.<pub-id pub-id-type="pmid">29926490</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0027">
                <mixed-citation publication-type="journal" id="clr13914-cit-0027"><string-name><surname>Persson</surname>, <given-names>G. R.</given-names></string-name>, <string-name><surname>Samuelsson</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lindahl</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Renvert</surname>, <given-names>S.</given-names></string-name> (<year>2010</year>). <article-title>Mechanical non‐surgical treatment of peri‐implantitis: a single‐blinded randomized longitudinal clinical study. II. Microbiological results</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>37</volume>(<issue>6</issue>), <fpage>563</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2010.01561.x</pub-id>
<pub-id pub-id-type="pmid">20507380</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0028">
                <mixed-citation publication-type="journal" id="clr13914-cit-0028"><string-name><surname>Polymeri</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Loos</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>Aronovich</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Steigmann</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Inglehart</surname>, <given-names>M. R.</given-names></string-name> (<year>2021</year>). <article-title>Risk factors, diagnosis and treatment of peri‐implantitis: A cross‐cultural comparison of U.S. and European periodontists’ considerations</article-title>. <source>Journal of Periodontology</source>. <pub-id pub-id-type="doi">10.1002/JPER.21-0010</pub-id>
</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0029">
                <mixed-citation publication-type="journal" id="clr13914-cit-0029"><string-name><surname>Polymeri</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>van der Horst</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Buijs</surname>, <given-names>M. J.</given-names></string-name>, &amp; <string-name><surname>Zaura</surname>, <given-names>E.</given-names></string-name> (<year>2021</year>). <article-title>Submucosal microbiome of peri‐implant sites: A cross‐sectional study</article-title>, <source>Journal of Clinical Periodontology</source>. <volume>48</volume>(<issue>9</issue>), <fpage>1228</fpage>–<lpage>1239</lpage>.<pub-id pub-id-type="pmid">34101220</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0030">
                <mixed-citation publication-type="journal" id="clr13914-cit-0030"><string-name><surname>Ramadan</surname>, <given-names>A.‐B.‐ E.</given-names></string-name>, &amp; <string-name><surname>Mitchell</surname>, <given-names>D. F.</given-names></string-name> (<year>1962</year>). <article-title>A roentgenographic study of experimental bone destruction</article-title>. <source>Oral Surgery, Oral Medicine, Oral Pathology</source>, <volume>15</volume>(<issue>8</issue>), <fpage>934</fpage>–<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1016/0030-4220(62)90087-7</pub-id>
<pub-id pub-id-type="pmid">14490054</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0031">
                <mixed-citation publication-type="journal" id="clr13914-cit-0031"><string-name><surname>Rams</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Degener</surname>, <given-names>J. E.</given-names></string-name>, &amp; <string-name><surname>van Winkelhoff</surname>, <given-names>A. J.</given-names></string-name> (<year>2014</year>). <article-title>Antibiotic resistance in human peri‐implantitis microbiota</article-title>. <source>Clinical Oral Implants Research</source>, <volume>25</volume>(<issue>1</issue>), <fpage>82</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1111/clr.12160</pub-id>
<pub-id pub-id-type="pmid">23551701</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0032">
                <mixed-citation publication-type="journal" id="clr13914-cit-0032"><string-name><surname>Renvert</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hirooka</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Polyzois</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Kelekis‐Cholakis</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Wang</surname>, <given-names>H. L.</given-names></string-name> (<year>2019</year>). <article-title>Diagnosis and non‐surgical treatment of peri‐implant diseases and maintenance care of patients with dental implants – Consensus report of working group 3</article-title>. <source>International Dental Journal</source>, <volume>69</volume>(<issue>Suppl 2</issue>), <fpage>12</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">31478575</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0033">
                <mixed-citation publication-type="journal" id="clr13914-cit-0033"><string-name><surname>Renvert</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Polyzois</surname>, <given-names>I.</given-names></string-name> (<year>2018</year>). <article-title>Treatment of pathologic peri‐implant pockets</article-title>. <source>Periodontology 2000</source>, <volume>76</volume>(<issue>1</issue>), <fpage>180</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12149</pub-id>
<pub-id pub-id-type="pmid">29239086</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0034">
                <mixed-citation publication-type="journal" id="clr13914-cit-0034"><string-name><surname>Renvert</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Polyzois</surname>, <given-names>I.</given-names></string-name>, &amp; <string-name><surname>Claffey</surname>, <given-names>N.</given-names></string-name> (<year>2012</year>). <article-title>Surgical therapy for the control of peri‐implantitis</article-title>. <source>Clinical Oral Implants Research</source>, <volume>23</volume>(<issue>Suppl 6</issue>), <fpage>84</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">23062132</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0035">
                <mixed-citation publication-type="journal" id="clr13914-cit-0035"><string-name><surname>Ronay</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Merlini</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Attin</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Schmidlin</surname>, <given-names>P. R.</given-names></string-name>, &amp; <string-name><surname>Sahrmann</surname>, <given-names>P.</given-names></string-name> (<year>2017</year>). <article-title>In vitro cleaning potential of three implant debridement methods. Simulation of the non‐surgical approach</article-title>. <source>Clinical Oral Implants Research</source>, <volume>28</volume>(<issue>2</issue>), <fpage>151</fpage>–<lpage>155</lpage>.<pub-id pub-id-type="pmid">26799360</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0036">
                <mixed-citation publication-type="journal" id="clr13914-cit-0036"><string-name><surname>Shibli</surname>, <given-names>J. A.</given-names></string-name>, &amp; <string-name><surname>Ferrari</surname>, <given-names>D. S.</given-names></string-name> (<year>2019</year>). <article-title>Microbiological and clinical effects of adjunctive systemic metronidazole and amoxicillin in the non‐surgical treatment of peri‐implantitis: 1 year follow‐up</article-title>. <source>Brazilian Oral Research</source>, <volume>33</volume>(<issue>suppl 1</issue>), <elocation-id>e080</elocation-id>.<pub-id pub-id-type="pmid">31576959</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0037">
                <mixed-citation publication-type="journal" id="clr13914-cit-0037"><string-name><surname>Silva</surname>, <given-names>M. P.</given-names></string-name>, <string-name><surname>Feres</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Oliveira Sirotto</surname>, <given-names>T. A.</given-names></string-name>, <string-name><surname>Silva Soares</surname>, <given-names>G. M.</given-names></string-name>, <string-name><surname>Velloso Mendes</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Faveri</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Figueiredo</surname>, <given-names>L. C.</given-names></string-name> (<year>2011</year>). <article-title>Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo‐controlled clinical trial</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>38</volume>(<issue>9</issue>), <fpage>828</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2011.01763.x</pub-id>
<pub-id pub-id-type="pmid">21762197</pub-id></mixed-citation>
              </ref>
              <ref id="clr13914-bib-0038">
                <mixed-citation publication-type="journal" id="clr13914-cit-0038"><string-name><surname>Stein</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Hammacher</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Michael</surname>, <given-names>S. S.</given-names></string-name> (<year>2018</year>). <article-title>Combination of ultrasonic decontamination, soft tissue curettage, and submucosal air polishing with povidone‐iodine application for non‐surgical therapy of peri‐implantitis: 12 Month clinical outcomes</article-title>. <source>Journal of Periodontology</source>, <volume>89</volume>(<issue>2</issue>), <fpage>139</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2017.170362</pub-id>
</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0039">
                <mixed-citation publication-type="journal" id="clr13914-cit-0039"><string-name><surname>Teughels</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Feres</surname>, <given-names>M.</given-names></string-name> (<year>2020</year>). <article-title>Adjunctive effect of systemic antimicrobials in periodontitis therapy: A systematic review and meta‐analysis</article-title>. <source>Journal of Clinical Periodontology</source>. <volume>47</volume>(<issue>Suppl 22</issue>), <fpage>257</fpage>–<lpage>281</lpage>.</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0040">
                <mixed-citation publication-type="journal" id="clr13914-cit-0040"><string-name><surname>Verdugo</surname>, <given-names>F.</given-names></string-name> (<year>2018</year>). <article-title>Risk of superinfection in peri‐implantitis after systemic broad spectrum antibiotics</article-title>. <source>International Journal of Periodontics &amp; Restorative Dentistry</source>, <volume>38</volume>(<issue>3</issue>), <fpage>443</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.11607/prd.2546</pub-id>
</mixed-citation>
              </ref>
              <ref id="clr13914-bib-0041">
                <mixed-citation publication-type="journal" id="clr13914-cit-0041"><string-name><surname>Walter</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Kulik</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Weiger</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Zitzmann</surname>, <given-names>N. U.</given-names></string-name>, &amp; <string-name><surname>Waltimo</surname>, <given-names>T.</given-names></string-name> (<year>2011</year>). <article-title>Additive or synergistic antimicrobial effects of amoxicillin and metronidazole on whole plaque samples: a preliminary report</article-title>. <source>Journal of the International Academy of Periodontology</source>, <volume>13</volume>(<issue>1</issue>), <fpage>11</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">21387982</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
